{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:19:36Z","timestamp":1788477576163,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02956-2","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:02:16Z","timestamp":1788476536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Infection and \u03b1-ketoglutarate\/oxygen inhibition converge to CDC20 to promote cancer cell aneuploidy"],"prefix":"10.1038","volume":"11","author":[{"given":"Yi-Neng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7900-5319","authenticated-orcid":false,"given":"Fu-Jiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui-Fang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Sen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Zhen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0829-3824","authenticated-orcid":false,"given":"Yi-Yuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9861-0330","authenticated-orcid":false,"given":"Jian-Yuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Cheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Zi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3674-9107","authenticated-orcid":false,"given":"Shi-Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"2956_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41580-023-00593-z","volume":"24","author":"AD McAinsh","year":"2023","unstructured":"McAinsh, A. D. & Kops, G. J. P. L. Principles and dynamics of spindle assembly checkpoint signalling. Nat. Rev. Mol. Cell Biol. 24, 543\u2013559 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2956_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41556-018-0243-8","volume":"21","author":"NK Chunduri","year":"2019","unstructured":"Chunduri, N. K. & Storchov\u00e1, Z. The diverse consequences of aneuploidy. Nat. Cell Biol. 21, 54\u201362 (2019).","journal-title":"Nat. Cell Biol."},{"key":"2956_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-cancerbio-042616-072231","volume":"1","author":"KA Knouse","year":"2017","unstructured":"Knouse, K. A., Davoli, T., Elledge, S. J. & Amon, A. Aneuploidy in cancer: seq-ing answers to old questions. Ann. Rev. Cancer Biol. 1, 335\u2013354 (2017).","journal-title":"Ann. Rev. Cancer Biol."},{"key":"2956_CR4","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.03023","volume":"3","author":"N Dephoure","year":"2014","unstructured":"Dephoure, N. et al. Quantitative proteomic analysis reveals posttranslational responses to aneuploidy in yeast. Elife 3, e03023 (2014).","journal-title":"Elife"},{"key":"2956_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41586-020-03114-6","volume":"590","author":"Y Cohen-Sharir","year":"2021","unstructured":"Cohen-Sharir, Y. et al. Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition. Nature 590, 486\u2013491 (2021).","journal-title":"Nature"},{"key":"2956_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/onc.2013.318","volume":"33","author":"S Zhang","year":"2014","unstructured":"Zhang, S. et al. Generation of cancer stem-like cells through the formation of polyploid giant cancer cells. Oncogene 33, 134\u2013134 (2014).","journal-title":"Oncogene"},{"key":"2956_CR7","doi-asserted-by":"publisher","first-page":"114719","DOI":"10.1016\/j.celrep.2024.114719","volume":"43","author":"C Germeys","year":"2024","unstructured":"Germeys, C. et al. Targeting EGLN2\/PHD1 protects motor neurons and normalizes the astrocytic interferon response. Cell Rep. 43, 114719 (2024).","journal-title":"Cell Rep."},{"key":"2956_CR8","doi-asserted-by":"publisher","first-page":"9907","DOI":"10.2147\/CMAR.S223421","volume":"11","author":"C Zhu","year":"2019","unstructured":"Zhu, C. et al. Downregulation of Proline Hydroxylase 2 and Upregulation of Hypoxia-Inducible Factor 1\u03b1 are associated with endometrial cancer aggressiveness. Cancer Manag. Res. 11, 9907\u20139912 (2019).","journal-title":"Cancer Manag. Res."},{"key":"2956_CR9","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/s41388-022-02203-2","volume":"41","author":"Y Jin","year":"2022","unstructured":"Jin, Y. et al. Inactivation of EGLN3 hydroxylase facilitates Erk3 degradation via autophagy and impedes lung cancer growth. Oncogene 41, 1752\u20131766 (2022).","journal-title":"Oncogene"},{"key":"2956_CR10","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1038\/s41388-022-02378-8","volume":"41","author":"S Strocchi","year":"2022","unstructured":"Strocchi, S., Reggiani, F., Gobbi, G., Ciarrocchi, A. & Sancisi, V. The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation. Oncogene 41, 3665\u20133679 (2022).","journal-title":"Oncogene"},{"key":"2956_CR11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"2956_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/jmcb\/mjy042","volume":"11","author":"LM Liu","year":"2019","unstructured":"Liu, L. M. et al. p53 upregulated by HIF-1\u03b1 promotes hypoxia-induced G2\/M arrest and renal fibrosis in vitro and in vivo. J. Mol. Cell Biol. 11, 371\u2013382 (2019).","journal-title":"J. Mol. Cell Biol."},{"key":"2956_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41588-018-0318-2","volume":"51","author":"V Bhandari","year":"2019","unstructured":"Bhandari, V. et al. Molecular landmarks of tumor hypoxia across cancer types. Nat. Genet. 51, 308\u2013318 (2019).","journal-title":"Nat. Genet."},{"key":"2956_CR14","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1002\/1097-0142(19911215)68:12<2608::AID-CNCR2820681215>3.0.CO;2-Y","volume":"68","author":"M Haraguchi","year":"1991","unstructured":"Haraguchi, M. et al. DNA Ploidy Is Associated with Growth-Potential in Gastric-Carcinoma. Cancer 68, 2608\u20132611 (1991).","journal-title":"Cancer"},{"key":"2956_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","volume":"19","author":"W Xu","year":"2011","unstructured":"Xu, W. et al. Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of \u03b1-Ketoglutarate-Dependent Dioxygenases. Cancer Cell 19, 17\u201330 (2011).","journal-title":"Cancer Cell"},{"key":"2956_CR16","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.molcel.2015.10.017","volume":"60","author":"F Li","year":"2015","unstructured":"Li, F. et al. NADP(+)-IDH Mutations Promote Hypersuccinylation that Impairs Mitochondria Respiration and Induces Apoptosis Resistance. Mol. Cell 60, 661\u2013675 (2015).","journal-title":"Mol. Cell"},{"key":"2956_CR17","doi-asserted-by":"publisher","first-page":"626229","DOI":"10.3389\/fcell.2021.626229","volume":"9","author":"M Tang","year":"2021","unstructured":"Tang, M., Bolderson, E., O\u2019Byrne, K. J. & Richard, D. J. Tumor Hypoxia Drives Genomic Instability. Front. Cell. Dev. Biol. 9, 626229 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"2956_CR18","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(95)91510-9","volume":"346","author":"JDH Morris","year":"1995","unstructured":"Morris, J. D. H., Eddleston, A. L. W. F. & Crook, T. Viral-Infection and Cancer. Lancet 346, 754\u2013758 (1995).","journal-title":"Lancet"},{"key":"2956_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.critrevonc.2015.10.017","volume":"98","author":"C Bozza","year":"2016","unstructured":"Bozza, C., Cinausero, M., Iacono, D. & Puglisi, F. Hepatitis B and cancer: A practical guide for the oncologist. Crit. Rev. Oncol. Hematol. 98, 137\u2013146 (2016).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"2956_CR20","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"EJ Crosbie","year":"2013","unstructured":"Crosbie, E. J., Einstein, M. H., Franceschi, S. & Kitchener, H. C. Human papillomavirus and cervical cancer. Lancet 382, 889\u2013899 (2013).","journal-title":"Lancet"},{"key":"2956_CR21","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1007\/s00018-019-03044-1","volume":"76","author":"AFA Mentis","year":"2019","unstructured":"Mentis, A. F. A., Boziki, M., Grigoriadis, N. & Papavassiliou, A. G. Helicobacter pylori infection and gastric cancer biology: tempering a double-edged sword. Cell. Mol. Life Sci. 76, 2477\u20132486 (2019).","journal-title":"Cell. Mol. Life Sci."},{"key":"2956_CR22","doi-asserted-by":"publisher","first-page":"e2076","DOI":"10.1002\/rmv.2076","volume":"29","author":"F Taheri","year":"2019","unstructured":"Taheri, F., Goudarzi, H. & Faghihloo, E. Aneuploidy and oncoviruses. Rev. Med. Virol. 29, e2076 (2019).","journal-title":"Rev. Med. Virol."},{"key":"2956_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cancergencyto.2007.09.009","volume":"180","author":"L Goldberg-Bittman","year":"2008","unstructured":"Goldberg-Bittman, L. et al. Random aneuploidy in chronic hepatitis C patients. Cancer Genet. Cytogenet. 180, 20\u201323 (2008).","journal-title":"Cancer Genet. Cytogenet."},{"key":"2956_CR24","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1101\/gad.348341.121","volume":"35","author":"M Trakala","year":"2021","unstructured":"Trakala, M. et al. Clonal selection of stable aneuploidies in progenitor cells drives high-prevalence tumorigenesis. Genes Dev. 35, 1079\u20131092 (2021).","journal-title":"Genes Dev."},{"key":"2956_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1101\/sqb.2017.82.033712","volume":"82","author":"P Lara-Gonzalez","year":"2017","unstructured":"Lara-Gonzalez, P., Kim, T. & Desai, A. Taming the Beast: Control of APC\/C(Cdc20)-Dependent Destruction. Cold Spring Harb. Symp. Quant. Biol. 82, 111\u2013121 (2017).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"2956_CR26","first-page":"678","volume":"15","author":"WN He","year":"2023","unstructured":"He, W. N. & Meng, J. CDC20: a novel therapeutic target in cancer. Am. J. Transl. Res. 15, 678\u2013693 (2023).","journal-title":"Am. J. Transl. Res."},{"key":"2956_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.semcancer.2021.03.003","volume":"81","author":"H Was","year":"2022","unstructured":"Was, H. et al. Polyploidy formation in cancer cells: How a Trojan horse is born. Semin. Cancer Biol. 81, 24\u201336 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"2956_CR28","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1038\/emboj.2010.112","volume":"29","author":"ME Harley","year":"2010","unstructured":"Harley, M. E., Allan, L. A., Sanderson, H. S. & Clarke, P. R. Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest. EMBO J. 29, 2407\u20132420 (2010).","journal-title":"EMBO J."},{"key":"2956_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10818","volume":"7","author":"LY Jia","year":"2016","unstructured":"Jia, L. Y., Li, B. & Yu, H. T. The Bub1-Plk1 kinase complex promotes spindle checkpoint signalling through Cdc20 phosphorylation. Nat. Commun. 7, 10818 (2016).","journal-title":"Nat. Commun."},{"key":"2956_CR30","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ccr.2011.09.004","volume":"20","author":"HS Kim","year":"2011","unstructured":"Kim, H. S. et al. SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC\/C Activity. Cancer Cell 20, 487\u2013499 (2011).","journal-title":"Cancer Cell"},{"key":"2956_CR31","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/nature05694","volume":"446","author":"F Stegmeier","year":"2007","unstructured":"Stegmeier, F. et al. Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities. Nature 446, 876\u2013881 (2007).","journal-title":"Nature"},{"key":"2956_CR32","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1091\/mbc.e14-02-0775","volume":"25","author":"WB Luo","year":"2014","unstructured":"Luo, W. B. et al. PHD3-mediated prolyl hydroxylation of nonmuscle actin impairs polymerization and cell motility. Mol. Biol. Cell 25, 2788\u20132796 (2014).","journal-title":"Mol. Biol. Cell"},{"key":"2956_CR33","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1073\/pnas.1314482111","volume":"111","author":"RS Singleton","year":"2014","unstructured":"Singleton, R. S. et al. OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation. Proc. Natl. Acad. Sci. USA 111, 4031\u20134036 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2956_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41422-023-00864-6","volume":"34","author":"YZ Mao","year":"2024","unstructured":"Mao, Y. Z. et al. Hypoxia induces mitochondrial protein lactylation to limit oxidative phosphorylation. Cell Res. 34, 13\u201330 (2024).","journal-title":"Cell Res."},{"key":"2956_CR35","doi-asserted-by":"publisher","first-page":"16997","DOI":"10.1073\/pnas.1900748116","volume":"116","author":"SJ Li","year":"2019","unstructured":"Li, S. J. et al. EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance. Proc. Natl. Acad. Sci. USA 116, 16997\u201317006 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2956_CR36","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s42255-022-00593-x","volume":"4","author":"SJ Li","year":"2022","unstructured":"Li, S. J. et al. Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel-Lindau syndrome. Nat. Metab. 4, 739\u2013758 (2022).","journal-title":"Nat. Metab."},{"key":"2956_CR37","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1038\/s42255-023-00927-3","volume":"5","author":"CB Thompson","year":"2023","unstructured":"Thompson, C. B. et al. A century of the Warburg effect. Nat. Metab. 5, 1840\u20131843 (2023).","journal-title":"Nat. Metab."},{"key":"2956_CR38","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","volume":"40","author":"KS Okunade","year":"2020","unstructured":"Okunade, K. S. Human papillomavirus and cervical cancer. J. Obstet. Gynaecol. 40, 602\u2013608 (2020).","journal-title":"J. Obstet. Gynaecol."},{"key":"2956_CR39","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413\u2013421 (2012).","journal-title":"Nat. Biotechnol."},{"key":"2956_CR40","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/10049","volume":"1","author":"P Clute","year":"1999","unstructured":"Clute, P. & Pines, J. Temporal and spatial control of cyclin B1 destruction in metaphase. Nat. Cell Biol. 1, 82\u201387 (1999).","journal-title":"Nat. Cell Biol."},{"key":"2956_CR41","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1074\/mcp.M500368-MCP200","volume":"5","author":"C Tagwerker","year":"2006","unstructured":"Tagwerker, C. et al. A tandem affinity tag for two-step purification under fully denaturing conditions: Application in ubiquitin profiling and protein complex identification combined with cross-linking. Mol. Cell. Proteom. 5, 737\u2013748 (2006).","journal-title":"Mol. Cell. Proteom."},{"key":"2956_CR42","doi-asserted-by":"publisher","first-page":"9797","DOI":"10.1073\/pnas.1512642112","volume":"112","author":"F Full","year":"2015","unstructured":"Full, F. & Gack, M. U. Delicate coordination of TRIM21\u2019s dual activity in virus neutralization and signaling. Proc. Natl. Acad. Sci. USA 112, 9797\u20139798 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2956_CR43","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1039\/c0cs00203h","volume":"40","author":"NR Rose","year":"2011","unstructured":"Rose, N. R., McDonough, M. A., King, O. N. F., Kawamura, A. & Schofield, C. J. Inhibition of 2-oxoglutarate-dependent oxygenases. Chem. Soc. Rev. 40, 4364\u20134397 (2011).","journal-title":"Chem. Soc. Rev."},{"key":"2956_CR44","doi-asserted-by":"publisher","first-page":"20712","DOI":"10.1074\/jbc.R115.662627","volume":"290","author":"S Markolovic","year":"2015","unstructured":"Markolovic, S., Wilkins, S. E. & Schofield, C. J. Protein hydroxylation catalyzed by 2-Oxoglutarate-dependent Oxygenases. J. Biol. Chem. 290, 20712\u201320722 (2015).","journal-title":"J. Biol. Chem."},{"key":"2956_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1126\/science.1170944","volume":"324","author":"SM Zhao","year":"2009","unstructured":"Zhao, S. M. et al. Glioma-derived mutations in dominantly inhibit IDH1 catalytic activity and induce HIF-1\u03b1. Science 324, 261\u2013265 (2009).","journal-title":"Science"},{"key":"2956_CR46","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/S0960-894X(02)00219-6","volume":"12","author":"LA McNeill","year":"2002","unstructured":"McNeill, L. A. et al. The use of dioxygen by HIF prolyl hydroxylase (PHD1). Bioorg. Med. Chem. Lett. 12, 1547\u20131550 (2002).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2956_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29420-3","volume":"13","author":"F Schiavoni","year":"2022","unstructured":"Schiavoni, F. et al. Aneuploidy tolerance caused by BRG1 loss allows chromosome gains and recovery of fitness. Nat. Commun. 13, 1731 (2022).","journal-title":"Nat. Commun."},{"key":"2956_CR48","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature19830","volume":"538","author":"A Kotschy","year":"2016","unstructured":"Kotschy, A. et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature 538, 477\u2013482 (2016).","journal-title":"Nature"},{"key":"2956_CR49","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1113\/JP275327","volume":"596","author":"KB Kennel","year":"2018","unstructured":"Kennel, K. B., Burmeister, J., Schneider, M. & Taylor, C. T. The PHD1 oxygen sensor in health and disease. J. Physiol. 596, 3899\u20133913 (2018).","journal-title":"J. Physiol."},{"key":"2956_CR50","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41579-018-0064-6","volume":"16","author":"NA Krump","year":"2018","unstructured":"Krump, N. A. & You, J. X. Molecular mechanisms of viral oncogenesis in humans. Nat. Rev. Microbiol. 16, 684\u2013698 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"2956_CR51","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1113\/EP091206","volume":"109","author":"DB Zoccal","year":"2024","unstructured":"Zoccal, D. B., Vieira, B. N., Mendes, L. R., Evangelista, A. B. & Leirao, I. P. Hypoxia sensing in the body: An update on the peripheral and central mechanisms. Exp. Physiol. 109, 461\u2013469 (2024).","journal-title":"Exp. Physiol."},{"key":"2956_CR52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2013.05.052","volume":"154","author":"VC Tam","year":"2013","unstructured":"Tam, V. C. et al. Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation. Cell 154, 213\u2013227 (2013).","journal-title":"Cell"},{"key":"2956_CR53","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.immuni.2025.06.017","volume":"58","author":"M Di Gioia","year":"2025","unstructured":"Di Gioia, M. et al. Epigenetic silencing of interleukin-10 by host-derived oxidized phospholipids supports a lethal inflammatory response to infections. Immunity 58, 2190\u20132207 (2025).","journal-title":"Immunity"},{"key":"2956_CR54","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccr.2009.08.020","volume":"16","author":"HC Huang","year":"2009","unstructured":"Huang, H. C., Shi, J., Orth, J. D. & Mitchison, T. J. Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. Cancer Cell 16, 347\u2013358 (2009).","journal-title":"Cancer Cell"},{"key":"2956_CR55","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ccr.2010.10.028","volume":"18","author":"E Manchado","year":"2010","unstructured":"Manchado, E. et al. Targeting mitotic exit leads to tumor regression in vivo: modulation by Cdk1, Mastl, and the PP2A\/B55\u03b1,\u03b4 phosphatase. Cancer Cell 18, 641\u2013654 (2010).","journal-title":"Cancer Cell"},{"key":"2956_CR56","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3389\/fphar.2020.00308","volume":"11","author":"MA Mandell","year":"2020","unstructured":"Mandell, M. A., Saha, B. & Thompson, T. A. The Tripartite nexus: autophagy, cancer, and Tripartite Motif-containing protein family members. Front. Pharmacol. 11, 308 (2020).","journal-title":"Front. Pharmacol."},{"key":"2956_CR57","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1038\/s41591-025-03793-6","volume":"31","author":"JY Park","year":"2025","unstructured":"Park, J. Y. et al. Global lifetime estimates of expected and preventable gastric cancers across 185 countries. Nat. Med. 31, 3020\u20133027 (2025).","journal-title":"Nat. Med."},{"key":"2956_CR58","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1038\/s41564-024-01835-2","volume":"9","author":"FDG Lima","year":"2024","unstructured":"Lima, F. D. G. & Molina, M. A. Uncovering the HPV types causing cervical cancer. Nat. Microbiol 9, 2795\u20132796 (2024).","journal-title":"Nat. Microbiol"},{"key":"2956_CR59","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/cancers15020533","volume":"15","author":"C Shen","year":"2023","unstructured":"Shen, C., Jiang, X., Li, M. & Luo, Y. Hepatitis virus and hepatocellular carcinoma: recent advances. Cancers 15, 533 (2023).","journal-title":"Cancers"},{"key":"2956_CR60","doi-asserted-by":"publisher","first-page":"105730","DOI":"10.1016\/j.phrs.2021.105730","volume":"170","author":"JS Nahand","year":"2021","unstructured":"Nahand, J. S. et al. Oncogenic viruses and chemoresistance: What do we know? Pharmacol. Res. 170, 105730 (2021).","journal-title":"Pharmacol. Res."},{"key":"2956_CR61","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pharmthera.2015.04.002","volume":"151","author":"LX Wang","year":"2015","unstructured":"Wang, L. X. et al. Targeting Cdc20 as a novel cancer therapeutic strategy. Pharmacol. Ther. 151, 141\u2013151 (2015).","journal-title":"Pharmacol. Ther."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02956-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02956-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02956-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:02:17Z","timestamp":1788476537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02956-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2956"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02956-2","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Shi-Min Zhao is an editorial board member of Signal Transduction and Targeted Therapy, but he has not been involved in the process of handling the manuscript. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"364"}}